[图书][B] Leukemia cell vaccine generation using lentiviral vectors
AC Logan - 2004 - search.proquest.com
Due to their ability to gain access to target cell genomes without mitosis-related dissolution
of the nuclear membrane, lentiviral vectors are useful tools for the genetic modification of …
of the nuclear membrane, lentiviral vectors are useful tools for the genetic modification of …
The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors
Our goal is to develop cell vaccines against leukemia cells, genetically modified to express
molecules with potent immune-stimulatory capacities. Pre-clinical evaluation of this …
molecules with potent immune-stimulatory capacities. Pre-clinical evaluation of this …
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement
Gene therapy of many genetic diseases requires permanent gene transfer into self-renewing
stem cells and restriction of transgene expression to specific progenies. Human …
stem cells and restriction of transgene expression to specific progenies. Human …
Development of gene therapy for hematopoietic stem cells using lentiviral vectors
NB Woods, A Ooka, S Karlsson - Leukemia, 2002 - nature.com
Lentiviral vectors are promising tools for the development of gene therapy since they can
transduce both quiescent and dividing target cells. Lentiviral vectors may be particularly …
transduce both quiescent and dividing target cells. Lentiviral vectors may be particularly …
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells
Lentiviral vectors are more efficient at transducing quiescent hematopoietic stem cells than
murine retroviral vectors. This characteristic is due to multiple karyophilic components of the …
murine retroviral vectors. This characteristic is due to multiple karyophilic components of the …
Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage–colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid …
R Stripecke, AA Cardoso, KA Pepper… - Blood, The Journal …, 2000 - ashpublications.org
Cell vaccines engineered to express immunomodulators have shown feasibility in
eliminating leukemia in murine models. Vectors for efficient gene delivery to primary human …
eliminating leukemia in murine models. Vectors for efficient gene delivery to primary human …
[图书][B] Transcriptional targeting of lentiviral vectors to the erythroblastic progeny of hematopoietic stem cells
F Lotti - 2003 - search.proquest.com
Correction of blood genetic disorders requires permanent gene transfer into self renewing,
hematopoietic stem cells (HSC), and regulation of transgene expression in specific cell …
hematopoietic stem cells (HSC), and regulation of transgene expression in specific cell …
Methods and compositions relating to improved lentiviral vectors and their applications
The present invention provides HIV-derived lentivectors which are safe, highly efficient, and
very potent for express ing transgenes for human gene therapy, especially, in human …
very potent for express ing transgenes for human gene therapy, especially, in human …
Methods and compositions relating to improved lentiviral vectors and their applications
The present invention provides HIV-derived lentivectors which are safe, highly efficient, and
very potent for express ing transgenes for human gene therapy, especially, in human …
very potent for express ing transgenes for human gene therapy, especially, in human …
相关搜索
- leukemia cells lentiviral vectors
- gene therapy lentiviral vectors
- transcriptional targeting lentiviral vectors
- leukemia cells gene delivery
- gene modification vector design
- stem cells vector design
- erythroblastic progeny lentiviral vectors
- efficient delivery lentiviral vectors
- stem cells gene modification
- granulocyte macrophage lentiviral vectors
- leukemia cells granulocyte macrophage
- stem cells lentiviral vectors
- gene delivery lentiviral vectors
- leukemia cells gene therapy
- stem cells gene therapy
- leukemia cells efficient delivery